Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126678983 | 12667898 | 3 | F | 20160822 | 20160819 | 20160831 | EXP | IT-PFIZER INC-2016393514 | PFIZER | GIOVANNACCI, ILARIA. AUTOFLUORESCENCE AS INDICATOR FOR DETECTING THE SURGICAL MARGINS OF MEDICATION-RELATED OSTEONECROSIS OF THE JAWS. MINERVA STOMATOLOGICA. 2016;65:248-52 | 73.00 | YR | M | Y | 0.00000 | 20160831 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126678983 | 12667898 | 1 | PS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | Y | 90621 | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||||
| 126678983 | 12667898 | 2 | SS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Y | 90621 | CONCENTRATE FOR SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126678983 | 12667898 | 1 | Plasma cell myeloma |
| 126678983 | 12667898 | 2 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126678983 | 12667898 | OT |
| 126678983 | 12667898 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126678983 | 12667898 | Fistula | |
| 126678983 | 12667898 | Osteonecrosis of jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |